Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Thymoma × Nivolumab × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 24 Melanoma 22 Stomach Neoplasms 8 Neoplasms 7 Carcinoma, Renal Cell 6 Carcinoma, Hepatocellular 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplasm Metastasis 5 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Hodgkin Disease 4 Urinary Bladder Neoplasms 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Uveal Melanoma 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Recurrence 2 Mesothelioma, Malignant 2 Lymphoma, B-Cell 2 Leukemia, Myeloid, Acute 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Merkel Cell 2 Carcinoma 2 Brain Neoplasms 2

Interventions

Radiotherapy 2 selinexor 1 pembrolizumab 1 isophosphamide mustard 1 epacadostat 1 envafolimab 1 Sunitinib 1 Ramucirumab 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Nivolumab 1 Leucovorin 1 Histocompatibility Testing 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Chemoradiotherapy 1 Carboplatin 1 68Ga-pentixafor 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03134118 2023-02-21

NIVOTHYM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Unknown

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡